Matches in SemOpenAlex for { <https://semopenalex.org/work/W596111962> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W596111962 endingPage "421" @default.
- W596111962 startingPage "416" @default.
- W596111962 abstract "Type 1 interferon is in widespread use as adjuvant therapy to inhibit melanoma progression. Considering the tumor-suppressive effects of local administration of interferon-β (IFN-β) on lymphatic metastasis, the present study was conducted to identify melanoma-suppressive molecules that are up-regulated by IFN-β treatment of lymphatic endothelial cells.Lymphatic endothelial cells, fibroblasts, and melanoma cells were treated with natural-type IFN-β, and melanoma cells were treated with CXCL10. Genome-wide oligonucleotide microarray analysis was performed using lymphatic endothelial cells with or without IFN-β treatment. Quantitative real-time reverse transcription-PCR and an enzyme-linked immunosorbent assay were performed to examine CXCL10 expression. A proliferation assay was performed to examine the effects of IFN-β and CXCL10 in melanoma cells.Genome-wide microarray analyses detected CXCL10 as a gene encoding a secretory protein that was up-regulated by IFN-β in lymphatic endothelial cells. IFN-β treatment significantly induced CXCL10 in dermal lymphatic endothelial cells and melanoma cells that are highly sensitive to IFN-β. CXCL10 reduced melanoma cell proliferation in IFN-β-sensitive cells as well as resistant cells. Melanoma cells in which CXCL10 was knocked down were sensitive to IFN-β. CXCR3-B, which encodes the CXCL10 receptor, was up-regulated in melanoma cells with high sensitivity to IFN-β and down-regulated in melanoma cells with medium to low sensitivity.Our data suggest that IFN-β suppresses proliferation and metastasis from the local lymphatic system and melanoma cells via CXCL10. Down-regulation of CXCR3-B by IFN-β may be associated with resistance to IFN-β." @default.
- W596111962 created "2016-06-24" @default.
- W596111962 creator A5003319013 @default.
- W596111962 creator A5054893133 @default.
- W596111962 creator A5068242406 @default.
- W596111962 date "2015-08-01" @default.
- W596111962 modified "2023-10-16" @default.
- W596111962 title "Tumor-suppressive effects of natural-type interferon-β through CXCL10 in melanoma" @default.
- W596111962 cites W1491881129 @default.
- W596111962 cites W1504846792 @default.
- W596111962 cites W1542936611 @default.
- W596111962 cites W1979481826 @default.
- W596111962 cites W1997919830 @default.
- W596111962 cites W2018559146 @default.
- W596111962 cites W2060204096 @default.
- W596111962 cites W2094650342 @default.
- W596111962 cites W2099289479 @default.
- W596111962 cites W2168143310 @default.
- W596111962 cites W2335274366 @default.
- W596111962 cites W4231399839 @default.
- W596111962 cites W4244068819 @default.
- W596111962 doi "https://doi.org/10.1016/j.bbrc.2015.06.122" @default.
- W596111962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26102027" @default.
- W596111962 hasPublicationYear "2015" @default.
- W596111962 type Work @default.
- W596111962 sameAs 596111962 @default.
- W596111962 citedByCount "7" @default.
- W596111962 countsByYear W5961119622016 @default.
- W596111962 countsByYear W5961119622019 @default.
- W596111962 countsByYear W5961119622020 @default.
- W596111962 countsByYear W5961119622021 @default.
- W596111962 countsByYear W5961119622022 @default.
- W596111962 crossrefType "journal-article" @default.
- W596111962 hasAuthorship W596111962A5003319013 @default.
- W596111962 hasAuthorship W596111962A5054893133 @default.
- W596111962 hasAuthorship W596111962A5068242406 @default.
- W596111962 hasConcept C12823836 @default.
- W596111962 hasConcept C13373296 @default.
- W596111962 hasConcept C181152851 @default.
- W596111962 hasConcept C203014093 @default.
- W596111962 hasConcept C25532541 @default.
- W596111962 hasConcept C2776178377 @default.
- W596111962 hasConcept C2777658100 @default.
- W596111962 hasConcept C2778690821 @default.
- W596111962 hasConcept C2780841837 @default.
- W596111962 hasConcept C502942594 @default.
- W596111962 hasConcept C5858377 @default.
- W596111962 hasConcept C86803240 @default.
- W596111962 hasConcept C8891405 @default.
- W596111962 hasConceptScore W596111962C12823836 @default.
- W596111962 hasConceptScore W596111962C13373296 @default.
- W596111962 hasConceptScore W596111962C181152851 @default.
- W596111962 hasConceptScore W596111962C203014093 @default.
- W596111962 hasConceptScore W596111962C25532541 @default.
- W596111962 hasConceptScore W596111962C2776178377 @default.
- W596111962 hasConceptScore W596111962C2777658100 @default.
- W596111962 hasConceptScore W596111962C2778690821 @default.
- W596111962 hasConceptScore W596111962C2780841837 @default.
- W596111962 hasConceptScore W596111962C502942594 @default.
- W596111962 hasConceptScore W596111962C5858377 @default.
- W596111962 hasConceptScore W596111962C86803240 @default.
- W596111962 hasConceptScore W596111962C8891405 @default.
- W596111962 hasIssue "2" @default.
- W596111962 hasLocation W5961119621 @default.
- W596111962 hasLocation W5961119622 @default.
- W596111962 hasOpenAccess W596111962 @default.
- W596111962 hasPrimaryLocation W5961119621 @default.
- W596111962 hasRelatedWork W1585815816 @default.
- W596111962 hasRelatedWork W1994889245 @default.
- W596111962 hasRelatedWork W2013888332 @default.
- W596111962 hasRelatedWork W2037075059 @default.
- W596111962 hasRelatedWork W2057559270 @default.
- W596111962 hasRelatedWork W2070463916 @default.
- W596111962 hasRelatedWork W2109220360 @default.
- W596111962 hasRelatedWork W2765724200 @default.
- W596111962 hasRelatedWork W2793584160 @default.
- W596111962 hasRelatedWork W3114293340 @default.
- W596111962 hasVolume "464" @default.
- W596111962 isParatext "false" @default.
- W596111962 isRetracted "false" @default.
- W596111962 magId "596111962" @default.
- W596111962 workType "article" @default.